Theravance Biopharma Inc’s filing revealed that its SVP, COMM & MEDICAL AFFAIRS Farnum Rhonda unloaded Company’s shares for reported $36000.0 on Nov 11 ’24. In the deal valued at $9.00 per share,4,000 shares were sold. As a result of this transaction, Farnum Rhonda now holds 322,743 shares worth roughly $2.77 million.
Then, Samaha Eli bought 999,800 shares, generating $7,798,440 in total proceeds. Upon buying the shares at $7.80, the 10% Owner now owns 9,511,150 shares.
Before that, Farnum Rhonda sold 4,000 shares. Theravance Biopharma Inc shares valued at $36,000 were divested by the SVP, COMM & MEDICAL AFFAIRS at a price of $9.00 per share. As a result of the transaction, Farnum Rhonda now holds 335,965 shares, worth roughly $2.88 million.
Leerink Partners downgraded its Theravance Biopharma Inc [TBPH] rating to a Market perform from a an Outperform in a research note published on August 06, 2024; the price target was decreased to $10 from $15. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in mid April with a ‘”a Buy”‘ rating. Evercore ISI also remained covering TBPH and has decreased its forecast on January 08, 2024 with a “an In-line” recommendation from previously “an Outperform” rating. SVB Leerink started covering the stock on May 23, 2022. It rated TBPH as “an Outperform”.
Price Performance Review of TBPH
On Friday, Theravance Biopharma Inc [NASDAQ:TBPH] saw its stock jump 1.66% to $8.58. Over the last five days, the stock has lost -2.28%. Theravance Biopharma Inc shares have fallen nearly -8.82% since the year began. Nevertheless, the stocks have fallen -12.09% over the past one year. While a 52-week high of $10.44 was reached on 01/03/25, a 52-week low of $7.44 was recorded on 01/16/25. SMA at 50 days reached $9.40, while 200 days put it at $8.92.
Levels Of Support And Resistance For TBPH Stock
The 24-hour chart illustrates a support level at 8.46, which if violated will result in even more drops to 8.35. On the upside, there is a resistance level at 8.64. A further resistance level may holdings at 8.71. The Relative Strength Index (RSI) on the 14-day chart is 33.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.26%. Stochastics %K at 10.25% indicates the stock is a buying.
How much short interest is there in Theravance Biopharma Inc?
A steep rise in short interest was recorded in Theravance Biopharma Inc stocks on 2024-12-31, dropping by -0.41 million shares to a total of 3.91 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 4.32 million shares. There was a decline of -10.38%, which implies that there is a negative sentiment for the stock.
